tirzepatide side effects eyes Mounjaro Eye Lawsuit [2026 Update] Weight-Loss Drug Linked to Lower

Semaglutide GLP-1 is a medication that is used to aid in weight management for adults who are overweight or obese

Mounjaro 2.5mg Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management

Final Thoughts Switching from semaglutide to tirzepatide is one of the more common transitions in GLP-1 therapyand for some people, its a logical next step when progress stalls or goals shift

Improved Beta Cell Function The medication may help preserve and improve the function of beta cells in the pancreas, which are responsible for insulin production

During the first few weeks, most participants experience reduced appetite and a pronounced feeling of fullness after small meals, alongside gastrointestinal effects such as nausea, bloating, and diarrhoea